Opening up a new pathway to fight cancer, researchers at the University of Pennsylvania have found a way to target an enzyme that is crucial to tumor growth while also blocking the mechanism that has made past attempts to target that enzyme resistant to treatment.
Sleep deprivation – typically administered in controlled, inpatient settings – rapidly reduces symptoms of depression in roughly half of depression patients, according the first meta-analysis on the subject in nearly 30 years, from researchers at the Perelman School of Medicine at the University of Pennsylvania.
Today in Philadelphia, Penn Medicine has deepened its commitment to the American Heart Association by announcing a three-year pledge as the market’s first ever Life is Why sponsor.
Chantell Evans, PhD, a postdoctoral fellow in the Perelman School of Medicine at the University of Pennsylvania, has been selected by the Howard Hughes Medical Institute (HHMI) as one of 15 early-career scientists in its first cohort of HHMI Hanna Gray Fellows.
The pending termination of DACA may reverse these mental health benefits for the 800,000 DACA beneficiaries, and trigger a public health crisis, according to an essay in the New England Journal of Medicine, co-authored by Atheendar. S. Venkataramani, MD, PhD, an assistant professor of medical ethics and health policy at Perelman School of Medicine at the University of Pennsylvania.
Researchers in the Perelman School of Medicine at the University Pennsylvania have found that gene expression actually continues during cell replication
Ben Z. Stanger, MD, PhD, an associate professor of Gastroenterology in the Perelman School of Medicine at the University of Pennsylvania, has been appointed director of the Penn Pancreatic Cancer Research Center (PCRC).
Now a new research network sponsored by the National Institutes of Health (NIH) is planning the largest-ever study of urinary stone disease—and how to help prevent it—with two major Philadelphia medical centers in the forefront.
A chemically modified version of the common blood thinner heparin may be the first promising method of preventing the harmful cascade of destruction to brain tissue that commonly follows traumatic brain injury (TBI), according to new research findings.
For Patients and the General Public: